APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal OTC Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Gastrointestinal OTC Drugs Industry Research Report 2026

20 December 2025122 pages

Choose your research edition.

Industry ResearchGastrointestinal OTC Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal OTC Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Gastrointestinal OTC Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal OTC Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal OTC Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Gastrointestinal OTC Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Gastrointestinal OTC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Gastrointestinal OTC Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Gastrointestinal OTC Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Gastrointestinal OTC Drugs include Boehringer Ingelheim, Perrigo, Procter & Gamble, Purdue Pharma, Reckitt Benckiser, Bayer, GlaxoSmithKline, Pfizer and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Gastrointestinal OTC Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Gastrointestinal OTC Drugs Market by Company

Boehringer Ingelheim

Perrigo

Procter & Gamble

Purdue Pharma

Reckitt Benckiser

Bayer

GlaxoSmithKline

Pfizer

Johnson & Johnson

Nestle

Sanofi

Teva Pharmaceutical

Abbott

Gastrointestinal OTC Drugs Segment by Type

Anti-Emetics

Laxatives

Anti-Flatulents

Anti-Diarrheals

PPIs

H2-Antaginists

Other

Gastrointestinal OTC Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Gastrointestinal OTC Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal OTC Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal OTC Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal OTC Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Gastrointestinal OTC Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Gastrointestinal OTC Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Gastrointestinal OTC Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Gastrointestinal OTC Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Gastrointestinal OTC Drugs Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Gastrointestinal OTC Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Gastrointestinal OTC Drugs Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Gastrointestinal OTC Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Gastrointestinal OTC Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Gastrointestinal OTC Drugs, Product Type & Application Table 14. Global Gastrointestinal OTC Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Gastrointestinal OTC Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Boehringer Ingelheim Company Information Table 19. Boehringer Ingelheim Business Overview Table 20. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio Table 22. Boehringer Ingelheim Recent Developments Table 23. Perrigo Company Information Table 24. Perrigo Business Overview Table 25. Perrigo Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Perrigo Gastrointestinal OTC Drugs Product Portfolio Table 27. Perrigo Recent Developments Table 28. Procter & Gamble Company Information Table 29. Procter & Gamble Business Overview Table 30. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio Table 32. Procter & Gamble Recent Developments Table 33. Purdue Pharma Company Information Table 34. Purdue Pharma Business Overview Table 35. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio Table 37. Purdue Pharma Recent Developments Table 38. Reckitt Benckiser Company Information Table 39. Reckitt Benckiser Business Overview Table 40. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio Table 42. Reckitt Benckiser Recent Developments Table 43. Bayer Company Information Table 44. Bayer Business Overview Table 45. Bayer Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Bayer Gastrointestinal OTC Drugs Product Portfolio Table 47. Bayer Recent Developments Table 48. GlaxoSmithKline Company Information Table 49. GlaxoSmithKline Business Overview Table 50. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio Table 52. GlaxoSmithKline Recent Developments Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Pfizer Gastrointestinal OTC Drugs Product Portfolio Table 57. Pfizer Recent Developments Table 58. Johnson & Johnson Company Information Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio Table 62. Johnson & Johnson Recent Developments Table 63. Nestle Company Information Table 64. Nestle Business Overview Table 65. Nestle Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Nestle Gastrointestinal OTC Drugs Product Portfolio Table 67. Nestle Recent Developments Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sanofi Gastrointestinal OTC Drugs Product Portfolio Table 72. Sanofi Recent Developments Table 73. Teva Pharmaceutical Company Information Table 74. Teva Pharmaceutical Business Overview Table 75. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio Table 77. Teva Pharmaceutical Recent Developments Table 78. Abbott Company Information Table 79. Abbott Business Overview Table 80. Abbott Gastrointestinal OTC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Abbott Gastrointestinal OTC Drugs Product Portfolio Table 82. Abbott Recent Developments Table 83. Global Gastrointestinal OTC Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global Gastrointestinal OTC Drugs Sales by Region (2021-2026) & (K Units) Table 85. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2021-2026) Table 86. Global Gastrointestinal OTC Drugs Sales by Region (2027-2032) & (K Units) Table 87. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2027-2032) Table 88. Global Gastrointestinal OTC Drugs Revenue by Region (2021-2026) & (US$ Million) Table 89. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2021-2026) Table 90. Global Gastrointestinal OTC Drugs Revenue by Region (2027-2032) & (US$ Million) Table 91. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2027-2032) Table 92. North America Gastrointestinal OTC Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 94. North America Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 95. North America Gastrointestinal OTC Drugs Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Gastrointestinal OTC Drugs Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe Gastrointestinal OTC Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 99. Europe Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 100. Europe Gastrointestinal OTC Drugs Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Gastrointestinal OTC Drugs Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific Gastrointestinal OTC Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 104. Asia Pacific Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 105. Asia Pacific Gastrointestinal OTC Drugs Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific Gastrointestinal OTC Drugs Revenue by Country (2027-2032) & (US$ Million) Table 107. South America Gastrointestinal OTC Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 109. South America Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 110. South America Gastrointestinal OTC Drugs Revenue by Country (2021-2026) & (US$ Million) Table 111. South America Gastrointestinal OTC Drugs Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 114. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 115. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2027-2032) & (US$ Million) Table 117. Global Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 118. Global Gastrointestinal OTC Drugs Sales by Type (2027-2032) & (K Units) Table 119. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2021-2026) Table 120. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2027-2032) Table 121. Global Gastrointestinal OTC Drugs Revenue by Type (2021-2026) & (US$ Million) Table 122. Global Gastrointestinal OTC Drugs Revenue by Type (2027-2032) & (US$ Million) Table 123. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2021-2026) Table 124. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2027-2032) Table 125. Global Gastrointestinal OTC Drugs Price by Type (2021-2026) & (US$/Unit) Table 126. Global Gastrointestinal OTC Drugs Price by Type (2027-2032) & (US$/Unit) Table 127. Global Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 128. Global Gastrointestinal OTC Drugs Sales by Application (2027-2032) & (K Units) Table 129. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2021-2026) Table 130. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2027-2032) Table 131. Global Gastrointestinal OTC Drugs Revenue by Application (2021-2026) & (US$ Million) Table 132. Global Gastrointestinal OTC Drugs Revenue by Application (2027-2032) & (US$ Million) Table 133. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2021-2026) Table 134. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2027-2032) Table 135. Global Gastrointestinal OTC Drugs Price by Application (2021-2026) & (US$/Unit) Table 136. Global Gastrointestinal OTC Drugs Price by Application (2027-2032) & (US$/Unit) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Gastrointestinal OTC Drugs Distributors List Table 140. Gastrointestinal OTC Drugs Customers List Table 141. Gastrointestinal OTC Drugs Industry Trends Table 142. Gastrointestinal OTC Drugs Industry Drivers Table 143. Gastrointestinal OTC Drugs Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Gastrointestinal OTC Drugs Product Image Figure 5. Global Gastrointestinal OTC Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Gastrointestinal OTC Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Gastrointestinal OTC Drugs Sales (2021-2032) & (K Units) Figure 8. Global Gastrointestinal OTC Drugs Average Price (US$/Unit) & (2021-2032) Figure 9. Anti-Emetics Product Image Figure 10. Laxatives Product Image Figure 11. Anti-Flatulents Product Image Figure 12. Anti-Diarrheals Product Image Figure 13. PPIs Product Image Figure 14. H2-Antaginists Product Image Figure 15. Other Product Image Figure 16. Retail Pharmacies Product Image Figure 17. Online Pharmacies Product Image Figure 18. Hospital Pharmacies Product Image Figure 19. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Gastrointestinal OTC Drugs, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Gastrointestinal OTC Drugs Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Gastrointestinal OTC Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Gastrointestinal OTC Drugs Sales by Region in 2025 Figure 25. Global Gastrointestinal OTC Drugs Revenue by Region in 2025 Figure 26. North America Gastrointestinal OTC Drugs Market Size by Country in 2025 Figure 27. North America Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2032) Figure 28. North America Gastrointestinal OTC Drugs Revenue Market Share by Country (2021-2032) Figure 29. United States Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Gastrointestinal OTC Drugs Market Size by Country in 2025 Figure 32. Europe Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2032) Figure 33. Europe Gastrointestinal OTC Drugs Revenue Market Share by Country (2021-2032) Figure 34. Germany Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Nordic Countries Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Gastrointestinal OTC Drugs Market Size by Country in 2025 Figure 41. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Country (2021-2032) Figure 43. China Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. China Taiwan Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Gastrointestinal OTC Drugs Market Size by Country in 2025 Figure 52. South America Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2032) Figure 53. South America Gastrointestinal OTC Drugs Revenue Market Share by Country (2021-2032) Figure 54. Mexico Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Brazil Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Gastrointestinal OTC Drugs Market Size by Country in 2025 Figure 58. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Country (2021-2032) Figure 60. Turkey Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. UAE Gastrointestinal OTC Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2021-2032) Figure 64. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2021-2032) Figure 65. Global Gastrointestinal OTC Drugs Price (US$/Unit) by Type (2021-2032) Figure 66. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2021-2032) Figure 67. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2021-2032) Figure 68. Global Gastrointestinal OTC Drugs Price (US$/Unit) by Application (2021-2032) Figure 69. Gastrointestinal OTC Drugs Value Chain Figure 70. Gastrointestinal OTC Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Gastrointestinal OTC Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Anti-Emetics
  • Laxatives
  • Anti-Flatulents
  • Anti-Diarrheals
  • PPIs
  • H2-Antaginists
  • Other
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Boehringer Ingelheim
  • Perrigo
  • Procter & Gamble
  • Purdue Pharma
  • Reckitt Benckiser
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Johnson & Johnson
  • Nestle
  • Sanofi
  • Teva Pharmaceutical
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Gastrointestinal OTC Drugs Market Size (2021-2032)
  4. 2.2.2 Global Gastrointestinal OTC Drugs Sales (2021-2032)
  5. 2.2.3 Global Gastrointestinal OTC Drugs Market Average Price (2021-2032)
  6. 2.3 Gastrointestinal OTC Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Anti-Emetics
  9. 2.3.3 Laxatives
  10. 2.3.4 Anti-Flatulents
  11. 2.3.5 Anti-Diarrheals
  12. 2.3.6 PPIs
  13. 2.3.7 H2-Antaginists
  14. 2.3.8 Other
  15. 2.4 Gastrointestinal OTC Drugs by Application
  16. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  17. 2.4.2 Retail Pharmacies
  18. 2.4.3 Online Pharmacies
  19. 2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Gastrointestinal OTC Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Gastrointestinal OTC Drugs Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Gastrointestinal OTC Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Gastrointestinal OTC Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Gastrointestinal OTC Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Gastrointestinal OTC Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Gastrointestinal OTC Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Gastrointestinal OTC Drugs, Established Date
  9. 3.9 Global Gastrointestinal OTC Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Boehringer Ingelheim
  2. 4.1.1 Boehringer Ingelheim Company Information
  3. 4.1.2 Boehringer Ingelheim Business Overview
  4. 4.1.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio
  6. 4.1.5 Boehringer Ingelheim Recent Developments
  7. 4.2 Perrigo
  8. 4.2.1 Perrigo Company Information
  9. 4.2.2 Perrigo Business Overview
  10. 4.2.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Perrigo Gastrointestinal OTC Drugs Product Portfolio
  12. 4.2.5 Perrigo Recent Developments
  13. 4.3 Procter & Gamble
  14. 4.3.1 Procter & Gamble Company Information
  15. 4.3.2 Procter & Gamble Business Overview
  16. 4.3.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio
  18. 4.3.5 Procter & Gamble Recent Developments
  19. 4.4 Purdue Pharma
  20. 4.4.1 Purdue Pharma Company Information
  21. 4.4.2 Purdue Pharma Business Overview
  22. 4.4.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio
  24. 4.4.5 Purdue Pharma Recent Developments
  25. 4.5 Reckitt Benckiser
  26. 4.5.1 Reckitt Benckiser Company Information
  27. 4.5.2 Reckitt Benckiser Business Overview
  28. 4.5.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio
  30. 4.5.5 Reckitt Benckiser Recent Developments
  31. 4.6 Bayer
  32. 4.6.1 Bayer Company Information
  33. 4.6.2 Bayer Business Overview
  34. 4.6.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Bayer Gastrointestinal OTC Drugs Product Portfolio
  36. 4.6.5 Bayer Recent Developments
  37. 4.7 GlaxoSmithKline
  38. 4.7.1 GlaxoSmithKline Company Information
  39. 4.7.2 GlaxoSmithKline Business Overview
  40. 4.7.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio
  42. 4.7.5 GlaxoSmithKline Recent Developments
  43. 4.8 Pfizer
  44. 4.8.1 Pfizer Company Information
  45. 4.8.2 Pfizer Business Overview
  46. 4.8.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Pfizer Gastrointestinal OTC Drugs Product Portfolio
  48. 4.8.5 Pfizer Recent Developments
  49. 4.9 Johnson & Johnson
  50. 4.9.1 Johnson & Johnson Company Information
  51. 4.9.2 Johnson & Johnson Business Overview
  52. 4.9.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio
  54. 4.9.5 Johnson & Johnson Recent Developments
  55. 4.10 Nestle
  56. 4.10.1 Nestle Company Information
  57. 4.10.2 Nestle Business Overview
  58. 4.10.3 Nestle Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Nestle Gastrointestinal OTC Drugs Product Portfolio
  60. 4.10.5 Nestle Recent Developments
  61. 4.11 Sanofi
  62. 4.11.1 Sanofi Company Information
  63. 4.11.2 Sanofi Business Overview
  64. 4.11.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Sanofi Gastrointestinal OTC Drugs Product Portfolio
  66. 4.11.5 Sanofi Recent Developments
  67. 4.12 Teva Pharmaceutical
  68. 4.12.1 Teva Pharmaceutical Company Information
  69. 4.12.2 Teva Pharmaceutical Business Overview
  70. 4.12.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio
  72. 4.12.5 Teva Pharmaceutical Recent Developments
  73. 4.13 Abbott
  74. 4.13.1 Abbott Company Information
  75. 4.13.2 Abbott Business Overview
  76. 4.13.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Abbott Gastrointestinal OTC Drugs Product Portfolio
  78. 4.13.5 Abbott Recent Developments
5 Global Gastrointestinal OTC Drugs Market Scenario by Region
  1. 5.1 Global Gastrointestinal OTC Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Gastrointestinal OTC Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Gastrointestinal OTC Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Gastrointestinal OTC Drugs Sales by Region: 2027-2032
  5. 5.3 Global Gastrointestinal OTC Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Gastrointestinal OTC Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Gastrointestinal OTC Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Gastrointestinal OTC Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Gastrointestinal OTC Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Gastrointestinal OTC Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Gastrointestinal OTC Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Gastrointestinal OTC Drugs Market Facts & Figures by Country
  15. 5.5.1 Europe Gastrointestinal OTC Drugs Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Gastrointestinal OTC Drugs Sales by Country (2021-2032)
  17. 5.5.3 Europe Gastrointestinal OTC Drugs Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Gastrointestinal OTC Drugs Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Gastrointestinal OTC Drugs Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Gastrointestinal OTC Drugs Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Gastrointestinal OTC Drugs Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Gastrointestinal OTC Drugs Market Facts & Figures by Country
  36. 5.7.1 South America Gastrointestinal OTC Drugs Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Gastrointestinal OTC Drugs Sales by Country (2021-2032)
  38. 5.7.3 South America Gastrointestinal OTC Drugs Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.8 Middle East and Africa Gastrointestinal OTC Drugs Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Gastrointestinal OTC Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Gastrointestinal OTC Drugs Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Gastrointestinal OTC Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Gastrointestinal OTC Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Gastrointestinal OTC Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Gastrointestinal OTC Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Gastrointestinal OTC Drugs Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Gastrointestinal OTC Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Gastrointestinal OTC Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Gastrointestinal OTC Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Gastrointestinal OTC Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Gastrointestinal OTC Drugs Value Chain Analysis
  2. 8.1.1 Gastrointestinal OTC Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Gastrointestinal OTC Drugs Production Mode & Process
  5. 8.2 Gastrointestinal OTC Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Gastrointestinal OTC Drugs Distributors
  8. 8.2.3 Gastrointestinal OTC Drugs Customers
9 Global Gastrointestinal OTC Drugs Analyzing Market Dynamics
  1. 9.1 Gastrointestinal OTC Drugs Industry Trends
  2. 9.2 Gastrointestinal OTC Drugs Industry Drivers
  3. 9.3 Gastrointestinal OTC Drugs Industry Opportunities and Challenges
  4. 9.4 Gastrointestinal OTC Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst